» Articles » PMID: 21601009

Nanomedicine Approaches in Vascular Disease: a Review

Overview
Journal Nanomedicine
Publisher Elsevier
Date 2011 May 24
PMID 21601009
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

From The Clinical Editor: Nanomedicine-based approaches have had a major impact on the treatment and diagnosis of malignancies and vascular diseases. This review discusses various nanomedicine approaches directed specifically toward vascular diseases during the past two decades, highlighting their advantages, limitations and offering new perspectives on future applications.

Citing Articles

Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.

Tang C, Zhou K, Wu D, Zhu H Int J Nanomedicine. 2024; 19:8831-8846.

PMID: 39220195 PMC: 11365508. DOI: 10.2147/IJN.S474888.


Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis.

Pang A, Dinesh T, Pang N, Dinesh V, Pang K, Yong C Molecules. 2024; 29(12).

PMID: 38930939 PMC: 11206617. DOI: 10.3390/molecules29122873.


In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles.

Rastegari B, Talepoor A, Khosropanah S, Doroudchi M ACS Omega. 2024; 9(1):658-674.

PMID: 38222576 PMC: 10785661. DOI: 10.1021/acsomega.3c06389.


Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders.

Singh A, Patel A, Chaudhary H, Yadav K, Minocha N Recent Pat Nanotechnol. 2023; 19(1):17-34.

PMID: 37464820 DOI: 10.2174/1872210517666230718115651.


Current and Novel Emerging Medical Therapies for Peripheral Artery Disease: A Literature Review.

Arabzadeh A, Faghfuri E, Soofiyani S, Abdolahinia E, Siapush S, Nejati-Koshki K Adv Pharm Bull. 2023; 13(2):259-268.

PMID: 37342373 PMC: 10278215. DOI: 10.34172/apb.2023.025.